You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 11,213,519


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 11,213,519 protect, and when does it expire?

Patent 11,213,519 protects JUBLIA and is included in one NDA.

This patent has twenty-one patent family members in fourteen countries.

Summary for Patent: 11,213,519
Title:Compositions and methods for treating diseases of the nail
Abstract: Methods and compositions for treating disorders of the nail and nail bed. Such compositions contain a vehicle in which all components of the composition are dissolved, suspended, dispersed, or emulsified, a non-volatile solvent, a wetting agent, and a pharmaceutically active ingredient that is soluble in the non-volatile solvent and/or a mixture of the vehicle and the non-volatile solvent, and which composition is effective in treating a disorder of the nail or nail bed.
Inventor(s): Winckle; Gareth (Biot, FR), Fieldson; Gregory T. (Morgantown, WV)
Assignee: BAUSCH HEALTH IRELAND LIMITED (Dublin, IE)
Application Number:16/722,715
Patent Claim Types:
see list of patent claims
Use; Composition; Formulation;
Patent landscape, scope, and claims:

United States Patent 11,213,519: A Detailed Analysis of Scope, Claims, and Patent Landscape

Introduction

United States Patent 11,213,519, titled "Compositions and methods for treating diseases of the nail," presents a comprehensive approach to addressing nail and nail bed disorders through innovative pharmaceutical formulations. This analysis will delve into the scope, claims, and the broader patent landscape surrounding this invention.

Background and Motivation

Nail and nail bed disorders are common and can significantly impact an individual's quality of life. Traditional treatments often have limited efficacy or undesirable side effects, highlighting the need for more effective and targeted therapies. The patent in question addresses this gap by introducing specific compositions and methods designed to treat these disorders effectively.

Scope of the Invention

The patent covers a range of compositions and methods aimed at treating nail and nail bed diseases. Here are the key components:

Pharmaceutical Composition

  • The composition includes a volatile and/or penetrating vehicle, a non-volatile solvent, an active pharmaceutical ingredient (API), and a wetting agent. The vehicle can be a volatile silicone, which may also serve as the wetting agent[1].

Components and Their Roles

  • Volatile and/or Penetrating Vehicle: This component is crucial for delivering the API to the nail or nail bed. It evaporates from the surface, facilitating the penetration of the API.
  • Non-Volatile Solvent: This solvent is dissolved, suspended, dispersed, or emulsified within the vehicle. It is preferably polar or semi-polar and ensures the API is soluble and effectively delivered.
  • Active Pharmaceutical Ingredient (API): The API must be soluble in the non-volatile solvent and/or the mixture of the vehicle and the non-volatile solvent. It is the core component that treats the nail disorder.
  • Wetting Agent: This agent, which may be the vehicle itself, enhances the spreadability and adherence of the composition to the nail surface[1].

Claims of the Patent

The patent includes several claims that define the scope of the invention:

Composition Claims

  • Claims describe the specific formulation of the composition, including the types of vehicles, solvents, APIs, and wetting agents used[1].

Method Claims

  • These claims outline the method of applying the composition to the nail surface, including the amount and duration necessary to ameliorate the symptoms of the disorder[1].

Specific Examples

  • The patent provides examples of how the composition can be formulated and applied, including the use of volatile silicones as both vehicles and wetting agents[1].

Patent Landscape

To understand the significance of this patent, it is essential to consider the broader patent landscape in the field of pharmaceuticals and dermatology.

Related Patents and Prior Art

  • Other patents in the field may address similar issues but with different formulations or methods. For instance, non-volatile solvents for hydrophobic drugs are discussed in other patents, such as those referenced in Pitre, U.S. patent application Ser. No. 11/432,410[1].

Global Patent System

  • The global patent system, facilitated by initiatives like the Global Dossier and Common Citation Document (CCD), ensures that patent applications and grants are harmonized across different jurisdictions. This helps in understanding the international scope and potential for this patent[4].

Legal and Regulatory Considerations

The patent is subject to various legal and regulatory frameworks:

35 U.S. Code § 112

  • This section of the U.S. Code outlines the requirements for patent specifications, including the description of the invention, the best mode of carrying out the invention, and the claims. The patent must comply with these requirements to be valid[5].

USPTO Guidelines

  • The United States Patent and Trademark Office (USPTO) provides guidelines and datasets, such as the Patent Claims Research Dataset, which help in analyzing and understanding the scope and claims of patents[3].

Economic and Market Impact

The economic and market impact of this patent can be significant:

Market Need

  • The demand for effective treatments for nail and nail bed disorders is substantial. A successful product based on this patent could capture a significant market share and improve patient outcomes.

Competitive Landscape

  • The patent landscape in dermatology and pharmaceuticals is highly competitive. This patent offers a unique formulation and method that could differentiate it from existing treatments and attract both investors and consumers.

Future Developments and Challenges

As with any patent, there are future developments and challenges to consider:

Research and Development

  • Continuous research and development are necessary to refine the formulation and expand its applications. This could involve clinical trials and further testing to ensure safety and efficacy.

Regulatory Approvals

  • Obtaining regulatory approvals from bodies like the FDA will be crucial for bringing the product to market. Compliance with regulatory requirements and successful clinical trials will be essential.

Litigation and Enforcement

  • The patent holder must be prepared to defend the patent against potential infringement. The study on a small claims patent court by ACUS highlights the complexities and considerations in patent litigation[2].

Key Takeaways

  • Innovative Formulation: The patent introduces a unique pharmaceutical composition for treating nail and nail bed disorders.
  • Specific Components: The composition includes a volatile vehicle, a non-volatile solvent, an API, and a wetting agent.
  • Method of Application: The method involves topically applying the composition to the affected nail surface.
  • Legal and Regulatory Compliance: The patent must comply with USPTO guidelines and 35 U.S. Code § 112.
  • Market Potential: The patent has significant market potential due to the demand for effective treatments.
  • Future Challenges: Continuous R&D, regulatory approvals, and potential litigation are key challenges.

Frequently Asked Questions (FAQs)

What is the main innovation of US Patent 11,213,519?

The main innovation is the specific pharmaceutical composition and method for treating nail and nail bed disorders using a volatile vehicle, a non-volatile solvent, an API, and a wetting agent.

How does the composition penetrate the nail?

The composition penetrates the nail through the use of a volatile and/or penetrating vehicle that evaporates from the surface, facilitating the delivery of the API.

What are the key components of the composition?

The key components include a volatile vehicle, a non-volatile solvent, an API, and a wetting agent.

What regulatory frameworks does the patent need to comply with?

The patent must comply with USPTO guidelines and the requirements outlined in 35 U.S. Code § 112.

What is the potential market impact of this patent?

The patent has significant market potential due to the high demand for effective treatments for nail and nail bed disorders.

Cited Sources

  1. US11213519B2 - Compositions and methods for treating diseases of the nail - Google Patents
  2. U.S. Patent Small Claims Court - ACUS
  3. Patent Claims Research Dataset - USPTO
  4. Search for patents - USPTO
  5. 35 U.S. Code § 112 - Specification - Law.Cornell.Edu

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 11,213,519

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Bausch JUBLIA efinaconazole SOLUTION;TOPICAL 203567-001 Jun 6, 2014 AB RX Yes Yes 11,213,519 ⤷  Subscribe ANTIMYCOTIC USES, SPECIFICALLY TREATMENT OF ONYCHOMYCOSIS; TOPICAL TREATMENT OF THE TOENAIL(S) DUE TO TRICHOPHYTON RUBRUM AND TRICHOPHYTON MENTAGROPHYTES ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 11,213,519

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 070083 ⤷  Subscribe
Australia 2008343795 ⤷  Subscribe
Australia 2013204596 ⤷  Subscribe
Australia 2016277570 ⤷  Subscribe
Brazil PI0822162 ⤷  Subscribe
Canada 2706114 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.